13F HOLDINGS REPORT
Caligan Partners LP
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001420506-25-000624
Total Value
$394.9M
Positions
14
Other Managers
0
Confidential Omitted
No
Holdings (14)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LIQUIDIA CORPORATION | LQDA | 8,118,592 | $115.5M | 29.26% |
| 2 | VERONA PHARMA PLC | 925050106 | 1,436,878 | $66.7M | 16.90% |
| 3 | EXELIXIS INC | EXEL | 1,525,730 | $50.8M | 12.87% |
| 4 | EVOLUS INC | EOLS | 2,692,388 | $29.7M | 7.53% |
| 5 | ANIKA THERAPEUTICS INC | ANIK | 1,435,130 | $23.6M | 5.98% |
| 6 | BIOCRYST PHARMACEUTICALS INC | BCRX | 2,995,932 | $22.5M | 5.71% |
| 7 | AGIOS PHARMACEUTICALS INC | AGIO | 626,280 | $20.6M | 5.21% |
| 8 | SAGE THERAPEUTICS INC | 78667J108 | 3,052,538 | $16.6M | 4.20% |
| 9 | Y-MABS THERAPEUTICS INC | 984241109 | 1,767,982 | $13.8M | 3.51% |
| 10 | MINERALYS THERAPEUTICS INC | MLYS | 1,011,155 | $12.4M | 3.15% |
| 11 | MERUS N V | N5749R100 | 255,000 | $10.7M | 2.72% |
| 12 | ABIVAX SA | AAVXF | 752,167 | $5.5M | 1.39% |
| 13 | VERRICA PHARMACEUTICALS INC | VRCA | 7,429,687 | $5.2M | 1.32% |
| 14 | ENANTA PHARMACEUTICALS INC | ENTA | 184,826 | $1.1M | 0.27% |